The Auto Channel
The Largest Independent Automotive Research Resource
The Largest Independent Automotive Research Resource
Official Website of the New Car Buyer

American Axle & Manufacturing Announces Management Changes


PHOTO

DETROIT, Sept. 15, 2008 - American Axle & Manufacturing, Inc. (AAM), announced today the following officer and executive appointments:

John J. Bellanti has been named executive vice president, Worldwide Operations. Previously, he served as AAM's group vice president, Manufacturing Services, Capital Planning & Cost Estimating.

Steven J. Proctor has been named president, AAM - Asia. Proctor previously served as AAM's vice president, Sales & Marketing prior to assuming his current position.

Mark S. Barrett has been appointed vice president, Engineering & Product Development. Barrett previously served as executive director, Engineering & Product Development.

Curt S. Howell has been appointed vice president, Driveline Full Frame Operations. Howell previously served as vice president, Global Driveline Operations.

John E. Jerge has been appointed vice president, Driveline Pascar Operations. Jerge previously served as vice president, Human Resources.

Robin Kendrick has been appointed vice president, Driveshaft & Halfshaft Operations. Kendrick previously served as general manager, Global Driveshaft & Halfshaft Operations.

Charles B. (Brad) Comeau has been appointed executive director, Human Resources. Comeau previously served as executive director, HR Operations.

John C. Salter has been appointed executive director, Sales & Marketing. Salter previously served as executive director, Driveline Programs.

Thomas J. Szymanski has been appointed executive director, Manufacturing Planning. Szymanski previously served as executive director, Corporate Manufacturing Services UniBody Vehicles Driveline.

"We are extremely pleased to announce the career enhancements of these officers and executives," said AAM Co-Founder, Chairman & CEO Richard E. Dauch. "As we restructure our business, these new appointments will allow our executive team to concentrate fully on our growth and operational objectives in our core and new markets."